Clinical Trials
7 trialsNCT03604315 2026-04-15
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT03432741 2025-05-26
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Mayo Clinic
Phase 1 Terminated
NCT00708045 2024-03-15
Chemobrain
University of Utah
Phase 1 Completed
NCT00039286 2015-12-24
Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00109785 2015-12-24
PET Scans in Patients With Locally Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed